FDA advisers endorse prasugrel for approval

02/3/2009 | Google · NYTimes.com

A group of FDA advisers unanimously voted to recommend approval for prasugrel, an anti-clotting medicine from Eli Lilly and Co. and Daiichi Sankyo. The panel also said prasugrel's label should warn physicians against its use in people who have suffered a stroke or are possible candidates for open-heart surgery.

View Full Article in:

Google · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC